Advertisement

Picture Berlin Partner Health Capital Computational Biology 2022 650x100px
Person › Details

Tim Van Hauwermeiren (Argen-X B.V.)

Van Hauwermeiren, Tim (Argen-X 201101 CEO before Ablynx BusDev Manager before P&G)

 

Organisations Organisation Argen-X B.V.
  Today Argen-X N.V. (Argenx) (Euronext + Nasdaq: ARGX)
  Group Argenx (Argen-X) (Group)
  Former/major organisation Ablynx N.V. (Euronext Brussels: ABLX, Nasdaq: ABLX)
  Group Sanofi (Group) [since May 2011]
Product Product SIMPLE Antibody™ discovery platform
     

   
Record changed: 2022-01-21

Advertisement

Picture EBD Group BIO-Europe 2022 Leipzig 650x200px


More documents for Tim Van Hauwermeiren


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Berlin Partner Voices from Berlin-Brandenburg Georg Duda 650x200px




» top